|
Journal of Ultrasound in Medicine, Vol 14, Issue 9 685-688, Copyright © 1995 by American Institute of Ultrasound in Medicine
Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium
R. Achiron, S. Lipitz, E. Sivan, M. Goldenberg and S. Mashiach
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Most menopausal patients with breast cancer receive tamoxifen therapy. In
these patients, TVS may show thickened, irregular cystic endometria. For
better visualization of these patients' uterine cavities, we performed
transvaginal sonohysterography. During vaginal ultrasonography, sterile
saline was introduced by transcervical 8 French Foley catheter into the
uterine cavity of 20 women who were referred with tamoxifen-associated
cystic thickened endometria. In eight women, transvaginal sonohysterography
provided the means to diagnose occult, free-floating endometrial polyps,
whereas in 12 women, the fluid contrast augmented the diagnosis of an
irregular cystic endometrial-myometrial junction. All 20 patients underwent
diagnostic hysteroscopy: eight polyps, none of which were malignant, were
confirmed and removed by hysteroscopic resection. Of the remaining 12
patients with an irregular endometrial-myometrial junction, endometrial
curettage showed no significant pathologic findings. Transvaginal
sonohysterography seems to enhance the differentiation between endometrial
polyps that should be resected by operative hysteroscopy and an abnormal
endometrial-myometrial junction that may benefit from biopsy sampling only.
This article has been cited by other articles:
|
|
|
|
 
J. S. Abramowicz
Ultrasonographic Contrast Media: Has the Time Come in Obstetrics and Gynecology?
J. Ultrasound Med.,
April 1, 2005;
24(4):
517 - 531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Hann, C. M. Kim, M. Gonen, R. Barakat, P. H. Choi, and A. M. Bach
Sonohysterography Compared With Endometrial Biopsy for Evaluation of the Endometrium in Tamoxifen-Treated Women
J. Ultrasound Med.,
November 1, 2003;
22(11):
1173 - 1179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M. Dudiak
Invited Commentary
RadioGraphics,
January 1, 2003;
23(1):
151 - 155.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Fong, R. Kung, A. Lytwyn, M. Trudeau, W. Chapman, P. Nugent, P. Glanc, L. Manchul, D. Szabunio, and T. Myhr
Endometrial Evaluation with Transvaginal US and Hysterosonography in Asymptomatic Postmenopausal Women with Breast Cancer Receiving Tamoxifen
Radiology,
September 1, 2001;
220(3):
765 - 773.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Hann, E. M. Gretz, A. M. Bach, and S. M. Francis
Sonohysterography for Evaluation of the Endometrium in Women Treated with Tamoxifen
Am. J. Roentgenol.,
August 1, 2001;
177(2):
337 - 342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Ascher, I. Imaoka, and J. M. Lage
Tamoxifen-induced Uterine Abnormalities: The Role of Imaging1
Radiology,
January 1, 2000;
214(1):
29 - 38.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
L. louffe Jr.
Selective Estrogen Receptor Modulators (SERMs) in Clinical Practice
Reproductive Sciences,
January 1, 2000;
7(1_suppl):
S38 - S46.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. J. Suh-Burgmann and A. Goodman
Surveillance for Endometrial Cancer in Women Receiving Tamoxifen
Ann Intern Med,
July 20, 1999;
131(2):
127 - 135.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. TESORO, A. F. BORGIDA, N. A. MACLAURIN, and C. M. ASUNCION
Transvaginal Endometrial Sonography in Postmenopausal Women Taking Tamoxifen
Obstet. Gynecol.,
March 1, 1999;
93(3):
363 - 366.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
